These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8382704)

  • 1. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
    Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
    J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
    Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
    J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
    Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
    Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioimmunoimaging (RII) and radioimmunotherapy (RIT) of human primary hepatic cancer (hPHC) with anti-PHC monoclonal antibody in tumor bearing nude mice].
    Shi L; Wu M; Chen H
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):20-3. PubMed ID: 7656780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunologic targeting and therapy with antihuman primary hepatic cancer monoclonal antibodies (Hepama I) in patients].
    Shi L; Wu M; Chen H
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):146-9. PubMed ID: 10743083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
    Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
    Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
    Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
    J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
    Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced radioimmunotherapeutic efficacy of a monoclonal antibody cocktail against SMMC-7721 human hepatocellular carcinoma.
    Song YQ; Wang GF; Dai XL; Xie H
    Cell Res; 1998 Sep; 8(3):241-7. PubMed ID: 9791737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy.
    Zeng ZC; Tang ZY; Liu KD; Yu YQ; Yang BH; Cai XJ; Xie H; Cao SL
    Nucl Med Commun; 1995 May; 16(5):378-85. PubMed ID: 7659390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
    Li KD
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and localization of iodine-131-labeled metuximab in patients with hepatocellular carcinoma.
    Zhang Z; Bian H; Feng Q; Mi L; Mo T; Kuang A; Tan T; Li Y; Lu W; Zhang Y; Zhang M; Tian R; Chen Z; Zhu P
    Cancer Biol Ther; 2006 Mar; 5(3):318-22. PubMed ID: 16481737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
    Liu Y; Wu MC; Qian GX
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
    Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
    Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
    Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer.
    Chen J; Wu H; Han D; Xie C
    Cancer Lett; 2006 Jan; 231(2):169-75. PubMed ID: 16399221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.